6 recruiting. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Recruiting 6 |
Follow Bronchitis: new trials by email Literature Review of Bronchitis trials Research Report on Bronchitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Bronchitis in Adult Patients Raphamin, Placebo - Bronchitis, Acute Bronchitis | Phase 3 | Recruiting | Materia Medica Holding | 308 | 2025-12-09 | 2026-06-29 |
| An Efficacy and Safety Study of DFL24498 in the Treatment of AKC DFL24498, Vehicle, dexamethasone sodium phosphate (DSP) ophthalmic solution - Atopic Keratoconjunctivitis | Phase 3 | Recruiting | Dompé Farmaceutici S.p.A | 153 | 2025-12-01 | 2026-09-21 |
| A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203) Tacrolimus (Tac), Methotrexate (MTX), Ruxolitinib (Rux) - Graft-versus-host Disease (GVHD) | Phase 3 | Recruiting | Incyte Corporation | 572 | 2025-04-02 | 2026-10-22 |
| A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease INCA034176, Placebo, Corticosteroids - Chronic Graft-versus-host-disease | Phase 3 | Recruiting | Incyte Corporation | 240 | 2025-01-21 | 2026-10-30 |
| Evaluation of the Efficacy of Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults Azithromycin Oral Tablet, Placebo - Sinusitis, Chronic, Sinus Infection Chronic | Phase 3 | Recruiting | Centre Hospitalier Intercommunal Creteil | 230 | 2022-11-21 | 2025-08-29 |
| Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic Features Albuterol Sulfate, 2.5 Mg/3 mL (0.083%) Inhalation Solution, Sodium Chloride 0.9% Inhl 3Ml - Bronchiolitis, Bronchodilator Agents | Phase 3 | Recruiting | Nemours Children's Clinic | 400 | 2022-07-08 | 2026-05-08 |
Bronchiolitis Obliterans Syndrome (4) · Bronchiolitis (1) · Graft vs Host Disease (1) · Sinusitis (1)
Bronchial Diseases (6) · Lung Diseases (6) · Lung Diseases, Obstructive (6) · Respiratory Tract Diseases (6) · Bronchiolitis (4) · Bronchiolitis Obliterans (4) · Immune System Diseases (4) · Organizing Pneumonia (4) · Graft vs Host Disease (3) · Infections (3) · Respiratory Tract Infections (3) · Nose Diseases (1) · Otorhinolaryngologic Diseases (1) · Paranasal Sinus Diseases (1)
Adrenal Cortex Hormones (1) · Albuterol (1) · Azithromycin (1) · Cyclophosphamide (1) · Methotrexate (1) · Methylprednisolone (1) · Mycophenolic Acid (1) · Ophthalmic Solutions (1) · Prednisolone (1) · Prednisone (1) · Sodium Chloride (1) · Tacrolimus (1) · Triamcinolone (1) · axatilimab (1) · dexamethasone 21-phosphate (1)
Incyte Corporation (2) · Centre Hospitalier Intercommunal Creteil (1) · Dompé Farmaceutici S.p.A (1) · Materia Medica Holding (1) · Nemours Children's Clinic (1)
United States (4) · France (2) · Italy (2) · Spain (2) · Australia (1) · Austria (1) · Canada (1) · Denmark (1) · Germany (1) · Ireland (1) · Japan (1) · Netherlands (1) · Russia (1) · United Kingdom (1)
Albert Assad, MD (1)
2023 (1), 2025 (1)